celltrion

Investment

top

Financial information

  • 바이오시밀러
  • 투자정보
  • 오시는 길
  • Ochang new construction plant
  • Biosimilar
Home  |  Investment  |  Financial information
Consolidated Statement of Financial Position
Unit : Million Won
2016년 ~ 2019년 연결 재무상태표
Classification 2019. 3Q 2018 2017 2016
Current assets 188,739 199,961 211,106 184,842
Non - Current assets 266,736 252,483 259,163 270,238
Total assets 455,475 452,444 470,269 455,080
Current liabilities 136,872 145,034 124,290 72,387
Non - Current liabilities 43,449 37,375 52,355 92,987
Total liabilities 180,321 182,409 176,645 165,374
Issued capital 263,549 310,878 309,705 307,298
Retained earnings 6,895 (45,123) (20,909) (22,833)
Elements of other stockholder's equity 4,710 4,280 4,828 5,241
Total equity 275,154 270,035 293,624 289,706
Total equity and liabilities 455,475 452,444 470,269 455,080
Consolidated Statement of Comprehensive Income
Unit : Million Won
2016년 ~ 2019년 연결 재무상태표
Classification 2019. 3Q 2018 2017 2016
Revenue(Sales) 128,646 146,880 135,860 104,811
Operating income(loss) 9,465 3,569 8,670 (2,005)
Profit (loss) before tax 5,046 (6,260) 2,464 (10,450)
Profit (loss) 4,329 (9,389) 2,715 (8,106)